Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Modine Manufacturing Company (MOD) vs Sanofi SA (SNY) Price & Performance

Modine Manufacturing CompanyTrade
Sanofi SATrade

Price performance (Past 24H)

Key statistics

Modine Manufacturing Company vs Sanofi SA — how do they compare? Modine Manufacturing Company trades at $245.92 (market cap $12.18B), while Sanofi SA trades at $44.05 (market cap $104.83B). The key difference: Sanofi SA is far larger — about 8.6× Modine Manufacturing Company's market cap, and Sanofi SA pays a 5.5% dividend while Modine Manufacturing Company pays none. Which is the better fit depends on your goals.

MODSNY
Market Cap
$12.18B$104.83B
Sector
TechnologyHealth
52-Week High
$306.89$52.34
52-Week Low
$93.71$41.33
Enterprise Value
$12.54B$121.32B
Dividend Yield
5.5%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Modine Manufacturing Company

MOD trades at $227.88, down 0.64% today, with a bearish technical signal from moving averages. The company reported strong earnings beats in recent quarters, with Q1 2026 EPS of $1.71 exceeding expectations. Revenue reached $2.58B in 2025, though net income margin is modest at 3.82%. Recent news includes institutional buying and executive appointments, while technical support sits near $221.

Analyst consensus is bullish with a $328.80 price target, but high P/E of 101.48 suggests premium valuation. Risks include margin pressure from supply chain challenges and competitive threats in data center cooling. The stock offers growth potential if margin expansion continues, but investors face volatility from technical weakness and execution risks.

Sanofi SA

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Modine Manufacturing Company

Modine Manufacturing Company is a global leader in thermal management technology and solutions. The company engineers, manufactures, and markets heat transfer products for a wide range of applications across the automotive, commercial, industrial, and HVAC (heating, ventilation, and air conditioning) markets. Modine's products include engine cooling systems, heat exchangers, and ventilation systems, providing critical thermal solutions for vehicles, data centers, and various equipment worldwide.

Read more on MOD

About Sanofi SA

Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.

Read more on SNY